RGS20
Regulator of G-protein signaling 20
Also known as: RGS20_HUMAN, RGSZ1, ZGAP1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O76081
- Gene
- RGS20
- Ensembl
- ENSG00000147509
- Chromosome
- 8
- Canonical length
- 388 aa
- Protein class
- Plasma proteins, Predicted intracellular proteins
OverviewNCBI Gene
The protein encoded by this gene belongs to the family of regulator of G protein signaling (RGS) proteins, which are regulatory and structural components of G protein-coupled receptor complexes. RGS proteins inhibit signal transduction by increasing the GTPase activity of G protein alpha subunits, thereby driving them into their inactive GDP-bound forms. This protein selectively binds to G(z)-alpha and G(alpha)-i2 subunits, and regulates their signaling activities. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2011]
Canonical amino-acid sequenceUniProt
388 residues, UniProt reviewed canonical sequence.
>O76081|RGS20
1 MPQLSQDNQE CLQKHFSRPS IWTQFLPLFR AQRYNTDIHQ ITENEGDLRA VPDIKSFPPA
61 QLPDSPAAPK LFGLLSSPLS SLARFFSHLL RRPPPEAPRR RLDFSPLLPA LPAARLSRGH
121 EELPGRLSLL LGAALALPGR PSGGRPLRPP HPVAKPREED ATAGQSSPMP QMGSERMEMR
181 KRQMPAAQDT PGAAPGQPGA GSRGSNACCF CWCCCCSCSC LTVRNQEDQR PTIASHELRA
241 DLPTWEESPA PTLEEVNAWA QSFDKLMVTP AGRNAFREFL RTEFSEENML FWMACEELKK
301 EANKNIIEEK ARIIYEDYIS ILSPKEVSLD SRVREVINRN MVEPSQHIFD DAQLQIYTLM
361 HRDSYPRFMN SAVYKDLLQS LSEKSIEALocalizationUniProt · AlphaFold · HPA
Whether an antibody against RGS20 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.54
- Highest tissue expression
- 37 nTPM
Expression across tissuesHPA
Tissue
- basal ganglia: 37 nTPM
- amygdala: 23 nTPM
- cerebral cortex: 23 nTPM
- hippocampal formation: 12 nTPM
- cerebellum: 5.4 nTPM
- hypothalamus: 4.9 nTPM
Single-cell type
- bergmann glia: 479 nCPM
- astrocytes: 271 nCPM
- cone photoreceptor cells: 211 nCPM
- ocular epithelial cells: 79 nCPM
- brain inhibitory neurons: 73 nCPM
- rod photoreceptor cells: 55 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- basal ganglia: 18 nTPM
- cerebral cortex: 12 nTPM
- amygdala: 9.5 nTPM
- hippocampal formation: 8.6 nTPM
- white matter: 7.9 nTPM
- thalamus: 7.3 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.14
- DepMap mean gene effect
- -0.04
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- G protein-coupled receptor signaling pathway
- negative regulation of signal transduction
- regulation of G protein-coupled receptor signaling pathway
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of RGS20 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads RGS20 as an antibody target. Whether an autoantibody or antibody against RGS20 could matter depends on whether native RGS20 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
RGS20 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label RGS20 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...